- Zacks•3 hours ago
Nivalis Therapeutics (NVLS), which is expected to report second-quarter 2016 results on Aug 1, posted a negative surprise of 15.91% last quarter.
- Associated Press•4 hours ago
Vertex Pharmaceuticals Inc. (VRTX) on Wednesday reported a loss of $64.5 million in its second quarter. The Boston-based company said it had a loss of 26 cents per share. Earnings, adjusted for stock option ...
Vertex Pharmaceuticals IncorporatedNasdaqGS
After hours: 94.00-2.01 (-2.09%) as of 6:12 PM EDT
|Bid||93.50 x 100|
|Ask||95.00 x 100|
|52wk Range||75.90 - 143.45|
|Day's Range||94.65 - 97.06|
|Avg Vol (3m)||1,672,741|
As of 4:00 PM EDT. Market closed.